Abstract
The ubiquity of infections makes thier detection a healthcare priority and an
ongoing opportunity for IVD companies. The aging of the population, and
emerging threats - MRSA, swine flu, and others have had an impact on this
market recently and will continue to in years to come. Kalorama Information
has been observing diagnostic markets for over a decade and has assembled in
this report, Infectious Disease Diagnostics, Kalorama Information has
assembled its best primary and secondary research.
This report focuses on products used for the diagnosis of bacterial and viral
infections. The major consideration is given to bacterial infections because
(a) they are the most frequent type of infections, and (b) the practical
aspects of diagnosis and therapy are more meaningful based both on medial
considerations and on market considerations. On the other hand, viral
infections are becoming of greater importance due to (a) the discovery of new
viral infections, (b) advances in the development of viral therapeutics, and
(c) the mutation viruses that cause drug resistance.
Included in this report:
- Market Size and Forecast for (Immunoassays, Rapid, DNA, ID/MIC )
- Overview of Key Infections and Their Impact on the Market
- Long-Term (10 Year) Trend in the Infectious Disease Diagnostics
Market
- Seven Conclusions and Recommendations
- Key Product Summary: Immunoassay Products, Molecular Diagnostic
Products, Amplification Products
- Discussion and Listing of ‘Home Brew' Products
- Discussion of Leading Competitors in the Market
- Increasing Use of Non Traditional Technologies in ID (FISH, Flow
Cytometry, etc.)
- The Role of NAT Testing Near-Term and Long-Term
- A Glossary of Important Terms
- Best Opportunities for IVD Companies
Market analysis in this report considers primarily the epidemiological
considerations and the sizes patient groups both in the United States and
globally, where available. We have accumulated the most recent data available,
understanding that virtually no organization does extensive studies on these
applications on a regular basis.
As with most Kalorama reports, this is a work of both market description and
analysis, along with recommendations. The analysis presented in this report is
based on data from a combination of company, government, industry,
institutional and private sources. It includes information from extensive
literature reviews and discussions with experts in the field, including
microbiologists, pathologists, hospital authorities, research scientists,
business development managers and marketing managers.
In this report global (world) revenue numbers are presented based on reported
and estimated manufacturer revenue.
| 
View Cart
